857 related articles for article (PubMed ID: 9162267)
1. Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis.
Johansson BR; Unger ML; Albertsson P; Casselbrant A; Nannmark U; Hokland M
Nat Immun; 1996-1997; 15(2-3):87-97. PubMed ID: 9162267
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment.
Johansson BR; Nannmark U
Nat Immun; 1996-1997; 15(2-3):98-106. PubMed ID: 9162268
[TBL] [Abstract][Full Text] [Related]
3. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
5. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells.
Nannmark U; Hokland ME; Agger R; Christiansen M; Kjaergaard J; Goldfarb RH; Bagge U; Unger M; Johansson BR; Albertsson PA; Basse PH
In Vivo; 2000; 14(5):651-8. PubMed ID: 11125549
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
Matsumoto G; Nghiem MP; Nozaki N; Schmits R; Penninger JM
J Immunol; 1998 Jun; 160(12):5781-9. PubMed ID: 9637488
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL
J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947
[TBL] [Abstract][Full Text] [Related]
8. A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin.
Goldfarb RH; Koelemij R; Muirhead KA; Ohlsson-Wilhelm BM; Gray BD; Kuppen PJ; Basse PH; al-Atrash G; Kitson RP
In Vivo; 2000; 14(1):101-4. PubMed ID: 10757065
[TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
11. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
[TBL] [Abstract][Full Text] [Related]
12. Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites.
Weisman Z; Evans DL; Jaso-Friedmann L
Nat Immun; 1996-1997; 15(6):269-84. PubMed ID: 9523279
[TBL] [Abstract][Full Text] [Related]
13. Activated T cells inhibit NK cell-mediated tumour rejection.
Wang XJ; Hu J; Yuan J; Peng YM; Gui L; He WF; Tan J; Luo GX; Wu J
Scand J Immunol; 2009 Apr; 69(4):337-41. PubMed ID: 19284498
[TBL] [Abstract][Full Text] [Related]
14. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy.
Nannmark U; Johansson BR; Bryant JL; Unger ML; Hokland ME; Goldfarb RH; Basse PH
Cancer Res; 1995 Oct; 55(20):4627-32. PubMed ID: 7553640
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2.
Basse PH; Goldfarb RH; Herberman RB; Hokland ME
In Vivo; 1994; 8(1):17-24. PubMed ID: 8054506
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
17. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren HG; Dilber MS
Exp Hematol; 2007 Dec; 35(12):1839-46. PubMed ID: 18036444
[TBL] [Abstract][Full Text] [Related]
18. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
19. Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals.
Nannmark U; Basse P; Johansson BR; Kuppen P; Kjergaard J; Hokland M
Nat Immun; 1996-1997; 15(2-3):78-86. PubMed ID: 9162266
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells.
Nannmark U; Kitson RP; Johansson BR; Rivett AJ; Goldfarb RH
Eur J Cell Biol; 1996 Dec; 71(4):402-8. PubMed ID: 8980912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
